Clinical Trial Update: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HLA-mismatched unrelated donor bone marrow transplantation with post-transplant cyclophosphamide; the study is completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Biphenotypic Leukemia
• Chronic Lymphocytic Leukemia
• Lymphoma
• Myelodysplastic Syndromes
• Undifferentiated Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Center for International Blood and Marrow Transplant Research | Conditions: Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL) | Phase 2 | Status: COMPLETED | Results posted: 2025-08-06